salicylic acid 0.02 MG/MG Topical Gel [Stridex]
RxNorm concept 1730425, branded drug (sbd). Prescribable name: Stridex Spot and T-Zone 2 % Topical Gel.
- RxCUI
- 1730425
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1730425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Stridex 0.02 MG/MG Topical Gel; Stridex Spot and T-Zone 2 % Topical Gel
Related concepts
- salicylic acid 0.02 MG/MG (SCDC, consists of)
- salicylic acid 0.02 MG/MG [Stridex] (SBDC, consists of)
- Topical Gel (DF, has dose form)
- Stridex (BN, has ingredient)
- salicylic acid 0.02 MG/MG Topical Gel (SCD, tradename of)
Linked data
NDCs
- 10157210101
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1730425 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1730425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1730425. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.